BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4381864)

  • 1. Potentiation of the noradrenaline-releasing action of tyramine by monoamine oxidase inhibitors.
    Spano PF
    J Pharm Pharmacol; 1966 Aug; 18(8):548. PubMed ID: 4381864
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of centrally released noradrenaline by extraneuronal monoamine oxidase and catechol-O-methyltransferase.
    Van Wijk M; Korf J
    Brain Res; 1976 Apr; 106(2):403-6. PubMed ID: 1276880
    [No Abstract]   [Full Text] [Related]  

  • 3. Catechol-O-methyltransferase. I. An enzymatic assay for cardiac norepinephrine.
    Nikodijevic B; Daly J; Creveling CR
    Biochem Pharmacol; 1969 Jul; 18(7):1577-84. PubMed ID: 5806102
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
    Dénes B; Greeff K; Tawfik H
    Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uptake of (3H)noradrenaline in the rat heart during increased sympathetic nervous activity associated with cold.
    Friedman E; Bhagat B
    J Pharm Pharmacol; 1968 Dec; 20(12):963-5. PubMed ID: 4388344
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase (MAO)-A but not MAO-B inhibitors potentiate tyramine-induced catecholamine release from PC12 cells.
    Youdim MB
    J Neurochem; 1990 Feb; 54(2):411-4. PubMed ID: 2299343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supersensitivity to tyramine during monoamine oxidase inhibition in man. Mechanism at the level of the adrenergic neuron.
    Pettinger WA; Oates JA
    Clin Pharmacol Ther; 1968; 9(3):341-4. PubMed ID: 5649986
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible functional differentiation between the stores from which adrenergic nerve stimulation, tyramine and amphetamine release noradrenaline.
    Obianwu HO
    Acta Physiol Scand; 1969; 75(1):92-101. PubMed ID: 5785154
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of pargyline on the response to CO2 stress].
    Alcalá T; Aguilar R; Bellido C
    Rev Esp Fisiol; 1985 Mar; 41(1):1-4. PubMed ID: 4001536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of epsilon amino caproic acid on adrenergic nerve function and tissue monoamine levels.
    Andén NE; Henning M; Obianwu H
    Acta Pharmacol Toxicol (Copenh); 1968; 26(2):113-29. PubMed ID: 4299609
    [No Abstract]   [Full Text] [Related]  

  • 11. Noradrenaline and tyramine action on isolated atrial muscle of endotoxin-treated guinea-pigs.
    Bhagat B; Cavanagh D; Merrild BN; Rana MW; Rao PS
    Br J Pharmacol; 1970 Aug; 39(4):688-95. PubMed ID: 5485145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory action of desmethylimipramine on the restoration of the pressor effect of tyramine and on the uptake of noradrenaline in the reserpinized dog.
    Kaumann AJ; Basso N
    Arch Int Pharmacodyn Ther; 1966 Mar; 160(1):113-23. PubMed ID: 5960851
    [No Abstract]   [Full Text] [Related]  

  • 13. The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine-treated mice.
    Carlsson A; Waldeck B
    J Pharm Pharmacol; 1967 Mar; 19(3):182-90. PubMed ID: 4382340
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of intraneuronal inactivation on the transmembranal uptake of l- and d-norepinephrine.
    Trendelenburg U; Draskóczy PR
    J Pharmacol Exp Ther; 1970 Nov; 175(2):521-2. PubMed ID: 5481716
    [No Abstract]   [Full Text] [Related]  

  • 15. [Apropos of various pharmacodynamic activities of pargyline in the rat and cat].
    Cession-Fossion A
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):298-305. PubMed ID: 5926872
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin, cocaine and desipramine: comparison of effects on blood pressure responses to norepinephrine, tyramine and phenylephrine in the pithed rat.
    Pals DT; Fulton RW; Masucci FD
    J Pharmacol Exp Ther; 1968 Jul; 162(1):85-91. PubMed ID: 4297803
    [No Abstract]   [Full Text] [Related]  

  • 17. [Noradrenaline liberating activity of orally administered tyramine and its potentiation by MAO inhibitors].
    Spano PF
    Boll Soc Ital Biol Sper; 1966 Oct; 42(20):1452-5. PubMed ID: 5972404
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of the augmentation of responses to indirectly acting sympathomimetic amines by monoamine oxidase inhibitors.
    Rand MJ; Trinker FR
    Br J Pharmacol Chemother; 1968 Jun; 33(2):287-303. PubMed ID: 5664149
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of bretylium on the cardiovascular response to tyramine in the rat.
    Clarke DE
    Arch Int Pharmacodyn Ther; 1969 Nov; 182(1):78-97. PubMed ID: 4391498
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the responses of single cortical neurones to tyramine and noradrenaline: effects of desipramine.
    Bevan P; Bradshaw CM; Pun RY; Slater NT; Szabadi E
    Br J Pharmacol; 1978 Aug; 63(4):651-7. PubMed ID: 687876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.